Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis.
about
Morning versus evening dosing of desloratadine in seasonal allergic rhinitis: a randomized controlled study [ISRCTN23032971Emerging role of antileukotriene therapy in allergic rhinitisTreatment of congestion in upper respiratory diseases.Hay fever in adolescents and adults.Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials.Next generation antihistamines: therapeutic rationale, accomplishments and advances.Review of fexofenadine in the treatment of chronic idiopathic urticaria.Fexofenadine: biochemical, pharmacokinetic and pharmacodynamic properties and its unique role in allergic disorders.Management of seasonal allergic rhinitis: comparative efficacy of the newer-generation prescription antihistamines.Optimal duration of allergic rhinitis clinical trials.Treatment for allergic rhinitis and chronic idiopathic urticaria: focus on oral antihistamines.Once-daily immediate-release fexofenadine and sustained-release pseudoephedrine combination: a new treatment option for allergic rhinitis.Pharmacotherapy of allergic eye disease.Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN).A direct comparison of efficacy between desloratadine and rupatadine in seasonal allergic rhinoconjunctivitis: a randomized, double-blind, placebo-controlled studyInhibition of the histamine-induced weal and flare response: a valid surrogate measure for antihistamine clinical efficacy?H1 antihistamines: current status and future directions.Rhinitis, rhinosinusitis and quality of life in children.Differential effects of fexofenadine on arachidonic acid metabolism in cultured human monocytes.Fexofenadine improves the quality of life and work productivity in Japanese patients with seasonal allergic rhinitis during the peak cedar pollinosis season.Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study.Patient perceptions of allergic rhinitis and quality of life: findings from a survey conducted in europe and the United StatesThe placebo effect in allergen-specific immunotherapy trials.Generic or disease-specific quality of life scales to characterize health status in allergic rhinitis?Fexofenadine reduces nasal congestion in perennial allergic rhinitis.A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis.An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers.Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis.Montelukast as an adjuvant to mainstay therapies in patients with seasonal allergic rhinitis.Glottis oedema due to loratadine.Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis.Comparative effects of desloratadine, fexofenadine, and levocetirizine on nasal adenosine monophosphate challenge in patients with perennial allergic rhinitis.Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies.Quality of life in patients with allergic rhinitis: a clinical trial comparing the use of bilastine versus loratadine.Relationship between allergic rhinitis, disturbed cognitive functions and psychological well-being.Onset of action for loratadine tablets for the symptomatic control of seasonal allergic rhinitis in adults challenged with ragweed pollen in the Environmental Exposure Unit: a post hoc analysis of total symptom score.Effect of grass pollen immunotherapy with Alutard SQ on quality of life in seasonal allergic rhinoconjunctivitis.
P2860
Q24804842-852D96D1-B654-4AD1-B542-BDE6CF0A296DQ28191844-83F4B473-86C8-4DFB-8B9C-9B326C2BD429Q30481520-480C2B63-6B3A-4B52-9041-3CD4F3B37846Q33949990-D44F90AB-7164-4A83-86AE-1F1A7559EBD5Q34221237-3C80BF7E-03F1-4CAB-B0D9-9C37FDEDD96BQ34660867-9E98ECFB-E938-49B4-BBC3-4D0FA86AB574Q34975901-EFE396A4-F72B-4E94-AE17-735ECCA739A3Q34988193-0AD53EB9-9034-4B5D-A9F2-18169E5354E8Q36207884-70679DD2-354A-4058-AB26-95D2C6B6FEF4Q36281063-25B54A5A-4A7A-4185-B5CD-50B6A8A0A2D4Q36309636-1AD6ABAE-0D68-4BC4-9906-796311895405Q36458473-1AFA6B5F-3962-464E-82F2-841B3377B4E7Q36491809-D756A2D3-4E19-47DF-A7AC-CA28FDA913A0Q36570549-1C4D89A1-00C2-4BA0-BD91-7F280A7748BAQ36638677-5C2909B8-21A2-4E17-BA70-C09B2624C109Q36759592-77BEFC01-2E08-476B-BEB6-A8C95A3C4AC0Q36834344-72620804-5CE7-4ED5-ABE8-C790C687FCDEQ36927691-7987751E-D095-4F19-9E1D-DF97A6E8BA54Q39359871-57642208-FECE-40EF-9AAC-F08577129526Q39371901-AB002C0C-AF9E-4034-8B02-1A7344337D5BQ39393362-C27647F4-3B81-4483-AAAD-FB1BFB28AC7BQ40617626-DA9B5D53-0E13-41D3-A1DF-D2DB3D528F74Q41846193-CBC901EA-57D7-453D-A264-8F30B374F60DQ43750140-64E4E236-C7AC-4EE7-8727-64E353B0A81BQ43795633-EDE44484-D85A-46B6-A0A0-E88882C32540Q43987754-A6313A71-BA02-415E-8F40-1B790AF4C847Q43987756-7B22CA78-2C9C-468C-B4D9-E394D1A55081Q44173557-A05F4A76-2F8C-4EDD-A5CD-107ECB5DB0DFQ44474645-BEEB3E7E-EF1B-4F14-9964-27B60EA57E44Q44692883-B1E1D578-75A8-4CCC-A763-A0D2ACC8221AQ44794327-E963CAF3-60D1-423B-B251-F1ACE1ED9BC3Q44841368-88C503E8-FE26-4AF2-B099-3B7683417037Q44946499-84E36CB5-DB3C-43E4-9831-64213F53FF1BQ47705701-5390AD89-E4D8-458B-B54D-3D0CE9ED2114Q48651403-009AB28C-F835-4397-AC99-0F328F007BBFQ49679128-53A1721C-DF9A-40A2-9FD2-298AF2BB7667Q53179735-CD7219E0-8948-42E8-89D6-CE5E0E304E9B
P2860
Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Comparison of the efficacy, sa ...... of seasonal allergic rhinitis.
@en
Comparison of the efficacy, sa ...... of seasonal allergic rhinitis.
@nl
type
label
Comparison of the efficacy, sa ...... of seasonal allergic rhinitis.
@en
Comparison of the efficacy, sa ...... of seasonal allergic rhinitis.
@nl
prefLabel
Comparison of the efficacy, sa ...... of seasonal allergic rhinitis.
@en
Comparison of the efficacy, sa ...... of seasonal allergic rhinitis.
@nl
P2860
P1476
Comparison of the efficacy, sa ...... of seasonal allergic rhinitis.
@en
P2093
Juniper EF
Van Cauwenberge P
P2860
P304
P356
10.1046/J.1365-2222.2000.00914.X
P577
2000-06-01T00:00:00Z